FIELD: veterinary medicine.
SUBSTANCE: invention relates to veterinary medicine, in particular to veterinary obstetrics, and can be used for the treatment of subclinical mastitis in lactating cows. To do this, on the 1st, 2nd and 3rd days of treatment, Biferon-B and recombinant interferon-λ are administered intramuscularly, each at a dose of 10 ml per animal with an activity of 1.0×104 IU/ml.
EFFECT: invention provides reduction of terms of treatment of subclinical mastitis in lactating cows and increase of treatment efficiency.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING SUBCLINICAL MASTITIS IN LACTATING COWS | 2021 |
|
RU2768609C1 |
METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2016 |
|
RU2619862C1 |
METHOD FOR COMPLEX THERAPY OF MASTITIS IN LACTATING COWS | 2020 |
|
RU2756125C1 |
PREVENTION OF MASTITIS IN LACTATING COWS | 2023 |
|
RU2804852C1 |
TREATMENT OF MASTITIS IN LACTATING COWS | 2022 |
|
RU2796986C1 |
METHOD OF TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING COWS | 2013 |
|
RU2538721C1 |
METHOD FOR PREVENTING MASTITIS IN LACTATING COWS | 2019 |
|
RU2731476C1 |
METHOD FOR PREVENTION OF SEROUS MASTITIS IN COWS | 2023 |
|
RU2795654C1 |
METHOD OF COMPREHENSIVE TREATMENT OF MASTITIS IN LACTATING COWS | 2013 |
|
RU2519349C1 |
METHOD OF PREVENTION MASTITIS OF LACTATING COWS | 2018 |
|
RU2683289C1 |
Authors
Dates
2022-11-10—Published
2022-04-11—Filed